Health ❯ Healthcare ❯ Pharmaceuticals ❯ Drug Approval

European Medicines Agency

EU Regulator Backs Myqorzo for Obstructive Hypertrophic Cardiomyopathy

The recommendation sends Cytokinetics’ aficamten to the European Commission for a final marketing authorization decision.

EU Grants Conditional Approval to Zemcelpro for Adults Needing Transplants Without a Matched Donor